Sign In
Buy ACHC
$25.73
+1.31 (+5.36%)
At Close: Jun 03, 2026
5 Analysts Have This to Say About Acadia Healthcare Co
05:10pm, Thursday, 05'th May 2022 Benzinga
Analysts have provided the following ratings for Acadia Healthcare Co (NASDAQ:ACHC) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
4
0
Acadia Healthcare Company, Inc. (ACHC) CEO Christopher H. Hunter on Q1 2022 Results - Earnings Call Transcript
11:56am, Wednesday, 04'th May 2022
Acadia Healthcare Company, Inc. (NASDAQ:ACHC ) Q1 2022 Earnings Conference Call May 4, 2022 9:00 AM ET Company Participants Christopher H. Hunter – Chief Executive Officer and Director David Duckwor
What Awaits Meridian Bioscience (VIVO) This Earnings Season?
02:47pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Meridian Bioscience's (VIVO) fiscal second-quarter results are likely to reflect continued strength across both its segments.
Has Acadia Healthcare (ACHC) Outpaced Other Medical Stocks This Year?
01:40pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Here is how Acadia Healthcare (ACHC) and Ono Pharmaceutical Co. (OPHLF) have performed compared to their sector so far this year.
Has Acadia Healthcare (ACHC) Outpaced Other Medical Stocks This Year?
11:17am, Tuesday, 03'rd May 2022
Here is how Acadia Healthcare (ACHC) and Ono Pharmaceutical Co. (OPHLF) have performed compared to their sector so far this year.
Mednax (MD) Q1 Earnings and Revenues Surpass Estimates
11:15am, Thursday, 28'th Apr 2022 Zacks Investment Research
Mednax (MD) delivered earnings and revenue surprises of 22.22% and 1.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Community Health Systems (CYH) Surpasses Q1 Earnings Estimates
10:05pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 7.69% and 1.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Acadia Healthcare (ACHC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
07:01pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Acadia Healthcare (ACHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Universal Health (UHS) Q1 Earnings Miss Mark, Tumble Y/Y
05:11pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Universal Health's (UHS) Q1 results reflect a steep expense level and lower admissions in its Behavioral Health Care Services segment, partially offset by revenue recognition.
Tenet Healthcare (THC) Q1 Earnings Beat Mark, Surge Y/Y
04:35pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Tenet Healthcare (THC) Q1 earnings gain from a healthy revenue stream, reduced expenses and operational efficiency.
Anthem (ANTM) Q1 Earnings Beat Estimates, Hikes '22 EPS View
02:32pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Anthem's (ANTM) first-quarter results indicate solid top-line growth and strong contribution from each of its businesses, partly offset by higher expenses.
Acadia Healthcare Announces Date for First Quarter 2022 Earnings Release
11:00am, Monday, 18'th Apr 2022
FRANKLIN, Tenn.--(BUSINESS WIRE)---- $ACHC--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its first quarter 2022 results on Tuesday, May 3, 2022, after the close
UnitedHealth's (UNH) Q1 Earnings Surpass Mark, Improve Y/Y
07:27pm, Thursday, 14'th Apr 2022 Zacks Investment Research
UnitedHealth's (UNH) Q1 results reflect gains from both its segments, Optum and UnitedHealthcare, along with higher revenues.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
01:40pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Select Medical Holdings: A Great Play On The Medical Space
04:14am, Tuesday, 05'th Apr 2022 Seeking Alpha
I believe Select Medical's profits & cash flows might be lower in 2022 than in 2021. Is SEM stock still an attractive long-term opportunity? Find out.
